Insiders · Profile

Gerber Brianna

Chief Financial Officer at Niagen Bioscience. Filing since 1 Dec 2023. CIK 0001942395

Company
Date
Role
Action
Shares
Amount
Of holding
1 Dec 2023
Chief Financial Officer
Bought
5,000
$7.05K
22.3%
1 decision on file.